You are here


Discovery research at Simmons Cancer Institute (SCI) provides the novel findings in cancer biology which will translate to better detection, treatment, and prevention options in the future. Research efforts at SCI are revealing fresh aspects in cellular and molecular mechanisms promoting tumor growth and metastases, new biomarkers for earlier detection and monitoring of therapeutic interventions, innovative agents and approaches for the treatment and prevention of cancer growth and proliferation. Members of SCI performing these discovery-based efforts include:

  • Laurent Brard, MD, PhD - (gynecologic oncology)
  • Deliang Cao, PhD - (metabolic pathways, antitumor activity & tumor selectivity)
  • Meghna Desai, MD - (hematology/oncology)
  • Randolph Elble, PhD - (cancer biology, tumor suppressors)
  • Sabha Ganai, MD, PhD
  • Edward Gershburg, PhD - (pathogenesis of human herpesvirus)
  • Dale Hales, PhD - (ovarian cancer prevention)
  • Daotai Nie, PhD - (molecular ordering in tumor progression)
  • Sophia Ran, PhD - (tumor biology, angiogenesis)
  • Krishna Rao, MD, PhD - (tumor genetics, breast cancer)
  • Andrew Wilber, PhD - (anti-tumor immunity)